Access to anti-retroviral drugs, female in South Sudan

South Sudan: Access to anti-retroviral drugs, female was 51.0% in 2024. ◆ Volatile

Latest (2024)
51.0%
Change on year
up 8.5%
World rank
118th
of 141 countries
All-time high
51.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in South Sudan, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 0 %2006: 0 %2007: 0 %2008: 0 %2009: 1 %2010: 1 %2011: 3 %2012: 3 %2013: 5 %2014: 9 %2015: 15 %2016: 16 %2017: 19 %2018: 24 %2019: 26 %2020: 31 %2021: 34 %2022: 40 %2023: 47 %2024: 51 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in South Sudan is 51.0%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 8.5% on the previous year and up 466.7% over ten years.

Over the whole period, access to anti-retroviral drugs, female in South Sudan peaked at 51.0% in 2024 and was at its lowest, 0.0%, in 2000.

South Sudan ranks 118th of 141 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in South Sudan, year by year

Annual values for Access to anti-retroviral drugs, female (%) in South Sudan, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 0.0%
2006 0.0%
2007 0.0%
2008 0.0%
2009 1.0%
2010 1.0% +0.0%
2011 3.0% +200.0%
2012 3.0% +0.0%
2013 5.0% +66.7%
2014 9.0% +80.0%
2015 15.0% +66.7%
2016 16.0% +6.7%
2017 19.0% +18.8%
2018 24.0% +26.3%
2019 26.0% +8.3%
2020 31.0% +19.2%
2021 34.0% +9.7%
2022 40.0% +17.6%
2023 47.0% +17.5%
2024 51.0% +8.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.1% 0.0% 1.0% 10
2010s 12.1% 1.0% 26.0% 10
2020s 40.6% 31.0% 51.0% 5

Countries ranked near South Sudan

  1. 116 Armenia 52.0% compare
  2. 116 Libya 52.0% compare
  3. 118 Belize 51.0% compare
  4. 118 Ghana 51.0% compare
  5. 118 Papua New Guinea 51.0% compare

See the full ranking of 160 places →

More gender data for South Sudan

All data for South Sudan →

Frequently asked questions

What is access to anti-retroviral drugs, female in South Sudan?
Access to anti-retroviral drugs, female in South Sudan was 51.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in South Sudan?
The highest recorded value was 51.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in South Sudan?
The lowest recorded value was 0.0% in 2000.
How does South Sudan rank for access to anti-retroviral drugs, female?
South Sudan ranks 118th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in South Sudan?
Over the last ten years it is up 466.7%. The long-run trend across the full record is volatile.
Where does this South Sudan data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in South Sudan. Statizoid, drawing on UNAIDS estimates. Retrieved 12 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/south-sudan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/south-sudan/">Access to anti-retroviral drugs, female in South Sudan</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.